Q BioMed Inc. Stock Other OTC
Equities
QBIO
US74736N1054
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | 0.2 | Sales 2022 | 0.28 | Capitalization | 1.35M |
---|---|---|---|---|---|
Net income 2021 | -8M | Net income 2022 | -2M | EV / Sales 2021 | 79,967,019 x |
Net Debt 2021 | 2.71M | Net Debt 2022 | 4.06M | EV / Sales 2022 | 19,023,098 x |
P/E ratio 2021 |
-1.39
x | P/E ratio 2022 |
-0.2
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.01% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 15-04-20 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 15-05-31 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 15-04-20 |
Rick Panicucci
BRD | Director/Board Member | 63 | 18-02-12 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |